Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EFFORT: Rosuvastatin in Metabolic Syndrome
NCT00815659Phase 4Completed
- Sponsor
- AstraZeneca
- Start
- Dec 2008
- Primary completion
- Mar 2010
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of rosuvastatin in metabolic syndrome, sponsored by AstraZeneca. Started Dec 2008; status: completed.
02
Drugs
rosuvastatin
03
Conditions
metabolic syndrome
Beyond the preview
Go deeper on NCT00815659.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00815659.